“…As the tumour suppressor BARD1 is involved in this response, it is possible that malignant cells show altered levels of polyadenylation of certain mRNAs. Supporting this idea, enhanced polyadenylation has been detected in certain tumour cells (Kumar et al , 1995; Scorilas, 2002), polyadenylation is inactivated in the M‐phase (Colgan et al , 1996, 1998) and expression levels of poly(A) polymerase can interfere with cell growth (Zhao and Manley, 1998). Moreover, antiproliferative transcription factors, such as BTG2 and TOB, have been shown to enhance deadenylation and subsequent mRNA decay (Ezzeddine et al , 2007; Mauxion et al , 2008).…”